PROLACTIN

Introduction to Prolactin

Prolactin (PRL) is a polypeptide hormone predominantly synthesized and secreted by the lactotroph cells of the anterior pituitary gland, although it is also produced in smaller quantities by other tissues, including the central nervous system, immune cells, and the decidua of the uterus. Functionally, Prolactin is best known for its critical role in reproductive physiology, specifically initiating and maintaining lactation in postpartum females. Historically, this hormone has been referenced by several synonyms, including Lactogenic Hormone and Luteo-Tropic Hormone (LTH), reflecting its diverse influence on both mammary gland function and ovarian corpus luteum maintenance in certain species. Understanding prolactin requires appreciating its classification as a stress hormone and its wide-ranging systemic effects that extend far beyond reproduction, influencing metabolism, immune function, and behavior.

While often categorized alongside growth hormone due to structural similarities, prolactin’s mechanism of action is unique, primarily involving binding to specific prolactin receptors (PRLRs) found across numerous cell types throughout the body. The sheer diversity of these receptor locations underscores the complexity of prolactin’s physiological reach, which includes neuroendocrine, metabolic, and homeostatic processes. The concentration of prolactin in the circulation is highly dynamic, fluctuating significantly in response to internal rhythms, environmental stimuli, and physiological states such as sleep, exercise, stress, and, most notably, pregnancy and nursing.

Synthesis and Molecular Structure of Prolactin

Prolactin is a single-chain protein comprising approximately 199 amino acid residues, characterized by three internal disulfide bonds essential for maintaining its tertiary structure and biological activity. The gene encoding prolactin (PRL gene) is located on chromosome 6 in humans. Within the anterior pituitary, the lactotroph cells are highly specialized for its synthesis and storage. Following translation, the preprolactin precursor is cleaved to yield the active hormone, which is then stored in secretory granules awaiting release. Prolactin exhibits significant structural polymorphism, circulating in various isoforms that possess differing biological potencies.

The major circulating form is the monomeric prolactin (approximately 23 kDa), which is the most biologically active form. However, larger isoforms are also important clinically, particularly “big prolactin” (dimeric or trimeric forms, 40–60 kDa) and “macroprolactin” (prolactin complexed with immunoglobulin G, >150 kDa). Macroprolactinemia, the predominant presence of this large, biologically less active complex in the bloodstream, is a common cause of elevated total prolactin levels detected in clinical assays, often leading to misdiagnosis if not specifically assessed. The differential activity and clearance rates of these various isoforms necessitate careful interpretation of serum prolactin measurements in clinical settings.

Regulation of Prolactin Secretion

Unlike most other anterior pituitary hormones, whose secretion is primarily driven by stimulating hypothalamic releasing hormones, prolactin secretion is primarily under tonic inhibitory control by the hypothalamus. The principal inhibitor is dopamine (also known as Prolactin Inhibitory Hormone, PIH), which is released from the tuberoinfundibular neurons and transported via the portal vasculature to the pituitary, where it acts upon D2 receptors on the lactotrophs to suppress prolactin synthesis and release.

The key mechanism for stimulating prolactin release involves the transient decrease of this dopaminergic inhibition or the introduction of potent secretagogues. The most significant physiological stimulus is the suckling reflex during nursing, which is a classic neuroendocrine pathway. Sensory input from the nipple is transmitted to the hypothalamus, leading to a rapid reduction in dopamine release and a subsequent surge in prolactin levels. This surge is essential for the immediate production of milk (galactopoiesis). Furthermore, several hypothalamic releasing factors, notably Thyrotropin-Releasing Hormone (TRH) and Vasoactive Intestinal Peptide (VIP), can act as prolactin secretagogues, particularly under conditions of stress or primary hypothyroidism.

Hormonal milieu plays a crucial modulatory role. High levels of estrogen, particularly during pregnancy, stimulate the proliferation of lactotrophs and enhance their sensitivity to releasing factors, preparing the mammary glands for lactation. Conversely, high progesterone levels during pregnancy inhibit the final stages of milk secretion, ensuring that full lactogenesis only occurs following parturition when progesterone levels rapidly decline. Pharmacological agents, including certain antipsychotics and antidepressants that block dopamine receptors, are also major non-physiological regulators, leading predictably to elevated prolactin levels.

Primary Reproductive Functions: Lactation and Infertility

Prolactin’s primary function in mammals is its involvement in mammogenesis (mammary gland development), lactogenesis (the initiation of milk secretion), and galactopoiesis (the maintenance of milk production). During pregnancy, prolactin works synergistically with estrogen, progesterone, and growth hormone to promote the proliferation and differentiation of alveolar epithelial cells within the mammary glands. However, the high levels of placental steroids present during gestation prevent full secretory activity.

The rapid drop in progesterone and estrogen immediately following childbirth removes the inhibitory block, allowing prolactin’s full secretory effect to manifest. The subsequent suckling action triggers the pulsatile release of prolactin, ensuring continued milk production. This hormonal activity is exemplified by the common clinical observation: After giving birth, a female’s prolactin levels dramatically increase, initiating the milk production cycle necessary for neonatal nutrition.

Beyond milk production, prolactin influences reproductive cyclicity. High prolactin levels, sustained by frequent nursing (the lactational amenorrhea method), inhibit the pulsatile release of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus. This suppression subsequently reduces the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), leading to a state of temporary infertility known as lactational amenorrhea. This mechanism serves as a natural spacing mechanism between births, although its efficacy as a contraceptive wanes as nursing frequency decreases.

Non-Reproductive Roles and Systemic Effects

The evolutionary history of prolactin suggests its roles are ancient and highly diverse, extending far beyond mammalian reproduction. In non-mammalian vertebrates, prolactin is crucial for osmoregulation—the maintenance of water and salt balance—particularly in fish adapting between freshwater and saltwater environments. While this osmoregulatory role is subtle in humans, prolactin does interact with vasopressin and aldosterone pathways, influencing fluid balance.

Furthermore, prolactin is a significant immunomodulator. Prolactin receptors are present on various immune cells, including T lymphocytes, B lymphocytes, and macrophages. Prolactin is considered a cytokine-like hormone, influencing immune cell proliferation, differentiation, and the production of various interleukins. Dysregulation of prolactin levels has been implicated in the pathogenesis of certain autoimmune diseases, such as systemic lupus erythematosus, where it may contribute to the breakdown of immune tolerance.

In metabolic health, prolactin influences glucose and lipid metabolism. It has complex interactions with insulin and adipokines. While prolactin is essential for metabolic adaptation during pregnancy, chronic elevation of prolactin levels outside of pregnancy has been linked to potential insulin resistance and alterations in body fat distribution. The hormone also plays a role in angiogenesis and hematopoiesis, further underscoring its systemic importance in maintaining tissue homeostasis and repair.

Prolactin and Psychological Function

The influence of prolactin on the central nervous system (CNS) is profound, playing a key role in mood, behavior, and the stress response. Prolactin is known to be released rapidly in response to psychological and physiological stressors, acting as a component of the stress axis, albeit often overshadowed by cortisol. Acute stress, physical exertion, and hypoglycemia all stimulate prolactin release, suggesting a role in adaptation and recovery.

Crucially, prolactin is deeply intertwined with parental behavior. High levels of prolactin, particularly postpartum, are strongly associated with the initiation and maintenance of maternal behaviors, including nesting, protective instincts, and bonding. Research has also demonstrated that prolactin levels can increase in non-lactating individuals, including fathers, in anticipation of or following infant interaction, suggesting that it contributes to the biological basis of paternal bonding and caregiving behaviors, possibly by modulating sensitivity to the infant’s cues.

Dysregulation of prolactin has been implicated in various psychiatric conditions. For instance, hyperprolactinemia, often induced by psychotropic medications (e.g., dopamine antagonists used for schizophrenia), is associated with symptoms such as lethargy, reduced libido, and depression, complicating the management of primary psychiatric disorders. The interaction between prolactin and dopamine pathways in the mesolimbic system highlights its integral role in modulating emotional processing and reward circuitry.

Hyperprolactinemia and Related Disorders

Hyperprolactinemia, defined as persistently elevated serum prolactin levels in the absence of physiological stimuli such as pregnancy or nursing, is the most common disorder related to this hormone. The clinical manifestations of hyperprolactinemia are diverse but primarily involve reproductive dysfunction due to the inhibitory effect on the hypothalamic-pituitary-gonadal axis.

Common symptoms include galactorrhea (inappropriate milk flow), amenorrhea (cessation of menstruation) or oligomenorrhea in women, and reduced libido, erectile dysfunction, and infertility in both sexes. In severe or chronic cases, the resultant hypogonadism can lead to decreased bone mineral density (osteopenia or osteoporosis).

The etiology of hyperprolactinemia is varied. The most common pathological cause is a prolactinoma, a benign tumor of the pituitary lactotrophs that secretes excessive prolactin. Other causes include the use of dopamine antagonist medications (antipsychotics, antiemetics), primary hypothyroidism (due to high TRH stimulating prolactin release), kidney or liver disease (reducing prolactin clearance), and hypothalamic or pituitary stalk compression interfering with dopamine transport. Treatment generally involves the use of dopamine agonists, such as cabergoline or bromocriptine, which suppress prolactin secretion by activating the D2 receptors on the lactotrophs.

Hypoprolactinemia and Clinical Considerations

While hyperprolactinemia is common, hypoprolactinemia—abnormally low levels of prolactin—is relatively rare and less frequently studied in clinical practice. The condition typically arises from significant damage to the anterior pituitary gland, such as in Sheehan’s syndrome (postpartum pituitary necrosis) or severe head trauma, or as an unintended side effect of high-dose dopamine agonist therapy used to treat Parkinson’s disease.

The most immediate and obvious clinical consequence in postpartum females is the failure to initiate or maintain lactation (agalactia). Beyond this reproductive failure, research suggests that chronic hypoprolactinemia may compromise immune function, given prolactin’s critical role as an immune system cofactor. Patients with hypoprolactinemia may experience subtle immune deficiencies, although definitive clinical syndromes directly attributable solely to low prolactin remain under investigation. The diagnosis of hypoprolactinemia often requires dynamic testing, utilizing stimuli like TRH administration to assess the pituitary reserve, providing insight into overall anterior pituitary function.